Biorex Super Speciality Private Limited

Biorex Super Speciality Private Limited - healthcare in Ernakulam, Kerala, India. FY 2026 financials & compliance.
CIN U51397KL2022PTC076090 Incorporated 13 June 2022 ROC Ernakulam HQ Ernakulam, Kerala, India
Active Private Limited Company healthcare MSME
Revenue · FY 2025
₹20.16 Cr
▲ 31% YoY
Net profit · FY 2025
₹80.65 Lakh
Net margin 4%
EBITDA · FY 2025
₹1.16 Cr
EBITDA margin 5.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Open charges
₹3 Cr
Satisfied ₹1 Cr
Company age
4 yrs
Est. 2022
Employees · EPFO
14
Provident fund records

About Biorex Super Speciality Private Limited

Data last updated:

Biorex Super Speciality Private Limited is a private limited company based in Ernakulam, Kerala, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 13 June 2022.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2022PTC076090. Its GSTIN is 32AAKCB8228Q1Z5 (Kerala).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Rahul Abraham Mamman (Managing Director) and Riyas Payanattil Thiruthimmel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Building No 13/189 – A4 First Floor Falcon Tower Maradu P O Ernakulam Kerala 682304, Kerala, India – 682304.

As per the financials filed for FY 2025, the company reported a revenue of ₹20.16 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹80.65 Lakh (net margin 4%) and EBITDA of ₹1.16 Cr (EBITDA margin 5.7%).

The company has about 14 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹3 Cr and satisfied charges of ₹1 Cr on record.

Biorex Super Speciality Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-KL-02-0057392).

Company details

CIN U51397KL2022PTC076090
Registration Number 076090
Incorporation Date 13 June 2022
ROC Ernakulam
Listing Status Unlisted
Company Status Active
MSME Classification MSME
Udyam Registration UDYAM-KL-02-0057392

Recognitions & Rankings of Biorex Super Speciality

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-KL-02-0057392

Contact details

Biorex Super Speciality Private Limited's registered office is in Ernakulam, Kerala. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Building No 13/189 – A4 First Floor Falcon Tower Maradu P O Ernakulam Kerala 682304, Kerala, India – 682304
  • Industry
    Healthcare, Medical Equipment Retail & Distribution

To see the full contact details of Biorex Super Speciality Private Limited, buy the company report.

Comprehensive company report
Biorex Super Speciality Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Biorex Super Speciality is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Biorex Super Speciality Private Limited, buy the company report.

Financials of Biorex Super Speciality Private Limited

FY 2025 filings available

Biorex Super Speciality Private Limited reported revenue of ₹20.16 Cr (up 31% YoY) for FY 2025.

Revenue · FY 2025
₹20.16 Cr ▲ 31%
Net profit · FY 2025
₹80.65 Lakh margin 4%
EBITDA · FY 2025
₹1.16 Cr margin 5.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 31%
EBITDA CAGR growth
1 year
▲ 248%

Revenue rose 31% in the latest year. EBITDA rose 248% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.16 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹80.65 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin5.7%
Net Profit Margin4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Biorex Super Speciality Private Limited, buy the company report.

Board of directors of Biorex Super Speciality Private Limited

Biorex Super Speciality has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Riyas Payanattil ThiruthimmelDirector09 Apr 20242 Years 7 MonthsCurrent
Rahul Abraham MammanManaging Director09 Apr 20242 Years 7 MonthsCurrent

Peer comparison

Biorex Super Speciality Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
S-Three Sales International Private Limited₹20.23 Cr (FY 2025)2.0%New Delhi, Delhi, India
Arrient Healthcare Private Limited₹20.18 Cr (FY 2025)31.0%Indore, Madhya Pradesh, India
Biorex Super Speciality Private Limitedthis company₹20.16 Cr (FY 2025)₹80.65 Lakh4%31.0%14Ernakulam, Kerala, India
Luxmi Medichem Private Limited₹20.11 Cr (FY 2025)-18.0%Kolkata, West Bengal, India
Drukst Biotech Private Limited₹20.04 Cr (FY 2023)16.0%Lucknow, Uttar Pradesh, India
Medi Biotek (India) Private Limited₹20.02 Cr (FY 2023)-56.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Biorex Super Speciality Private Limited, buy the company report.

Auditor

Biorex Super Speciality Private Limited is audited by SAVR & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SAVR & ASSOCIATESFY 2023019420S

Shareholding

The shareholding of Biorex Super Speciality Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Biorex Super Speciality Private Limited, buy the company report.

Charges & borrowings

Open charges
₹3 Cr
Satisfied charges
₹1 Cr
Breakdown by lending institutions
Others₹3.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Feb 2025101057619Others₹3 CrOpen
26 Jun 2023100747035Axis Bank Limited₹1 CrSatisfied

To see the full charge records of Biorex Super Speciality Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Biorex Super Speciality Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Biorex Super Speciality Private Limited has a workforce of 14 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
14
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2714
FY 2025-26

To see the full employee and EPFO history of Biorex Super Speciality Private Limited, buy the company report.

GST

Biorex Super Speciality has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AAKCB8228Q1Z5KeralaActive25 Jul 2022

To see the full GST registrations and return filing status of Biorex Super Speciality Private Limited, buy the company report.

Recent activity

Biorex Super Speciality Private Limited has 8 board changes on record since 2022: 5 appointments and 3 cessations. The latest: Shijan Puthusseril Paul ceased to be Managing Director on 13 Feb 2025.

Charges
A charge with Others of Rs. 300.00 Lakh registered on 24 Feb 2025 with Charge ID 101057619 was modified on 02 Feb 2026.
AGM
Biorex Super Speciality Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biorex Super Speciality Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge registered on 26 Jun 2023 via Charge ID 100747035 with Axis Bank Limited was fully satisfied on 20 Mar 2025.
Charges
A charge with Others amounted to Rs. 300.00 Lakh with Charge ID 101057619 was registered on 24 Feb 2025.
Ceased
Shijan Puthusseril Paul ceased to be Managing Director.
Ceased
Shino Sebastian ceased to be Managing Director.
Ceased
Jiji Chamakkadu Mathai ceased to be Director.
Appointed
Jiji Chamakkadu Mathai was appointed as Director.
Appointed
Rahul Abraham Mamman was appointed as Managing Director.
Appointed
Riyas Payanattil Thiruthimmel was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 100747035 was registered on 26 Jun 2023.

3 earlier events are in the company report.

Frequently asked questions

Biorex Super Speciality is an active private limited company based in Ernakulam, Kerala, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 13 June 2022 (4+ years old) and is registered under CIN U51397KL2022PTC076090.

Biorex Super Speciality has 2 current directors:

The latest financial statements of Biorex Super Speciality on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Biorex Super Speciality is 32AAKCB8228Q1Z5, registered in Kerala.

The CIN (Corporate Identification Number) of Biorex Super Speciality is U51397KL2022PTC076090. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Biorex Super Speciality was incorporated on 13 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ernakulam.

The peers of Biorex Super Speciality by revenue are S-Three Sales International Private Limited, Arrient Healthcare Private Limited, Luxmi Medichem Private Limited, Drukst Biotech Private Limited, Medi Biotek (India) Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Shijan Puthusseril Paul ceased to be Managing Director on 13 Feb 2025. Shino Sebastian ceased to be Managing Director on 13 Feb 2025. Jiji Chamakkadu Mathai ceased to be Director on 06 Jan 2025. Biorex Super Speciality has 8 board changes on record in total.

Yes, Biorex Super Speciality is registered as an MSME under Udyam registration (number: UDYAM-KL-02-0057392).

The registered office of Biorex Super Speciality is at Building No 13189 – A4 First Floor Falcon Tower Maradu P O Ernakulam Kerala 682304, Kerala, India – 682304.

Biorex Super Speciality operates in the healthcare industry, in the medical equipment retail and distribution segment.